STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Lifecore Biomedical (NASDAQ: LFCR) has announced plans to host a virtual investor day on Thursday, November 21, 2024, from 8:00 to 9:30 a.m. Eastern Time. The event, scheduled before market opening, will feature presentations from the company's senior management team discussing business strategies and future growth plans.

Interested participants can access the live webcast or archived recording through the Events & Presentations section on Lifecore's investor webpage at ir.lifecore.com/events-presentations. The company, operating as a fully integrated contract development and manufacturing organization (CDMO), aims to provide comprehensive insights into its operations and future direction.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will host a virtual investor day on Thursday, November 21, 2024, prior to market open. The event will take place from 8:00 – 9:30 a.m. Eastern Time and be available via webcast. During the event, members of Lifecore’s senior management team will discuss the company’s business and strategy for growth in the future, among other topics.

To listen to the live webcast, or access the archived webcast, please visit the Events & Presentations section of Lifecore’s investor web page at: https://ir.lifecore.com/events-presentations.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.


FAQ

When is Lifecore Biomedical (LFCR) hosting its virtual investor day in 2024?

Lifecore Biomedical (LFCR) will host its virtual investor day on Thursday, November 21, 2024, from 8:00 to 9:30 a.m. Eastern Time, before market open.

How can investors access Lifecore Biomedical's (LFCR) November 2024 virtual investor day?

Investors can access the live webcast or archived recording through the Events & Presentations section on Lifecore's investor webpage at ir.lifecore.com/events-presentations.

What topics will be covered during Lifecore Biomedical's (LFCR) virtual investor day?

The senior management team will discuss the company's business operations, strategy for growth, and future plans during the virtual investor day.
Lifecore Biomedical Inc

NASDAQ:LFCR

LFCR Rankings

LFCR Latest News

LFCR Latest SEC Filings

LFCR Stock Data

295.98M
36.71M
1.99%
76.48%
6.93%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CHASKA